When they compared post-mortem brain tissues from patients with MS to controls, they found significant increases in the detection, and expression, of ERVWE1 env in MS brains while finding no increase in detection or expression of the AF123882 clone. This evidence concerns the gene ERVW-1 and myeloid sarcoma.